Cognizant Collaborates With Alnylam as Technology Services Partner to Scale IT Operations
Cognizant Collaborates With Alnylam as Technology Services Partner to Scale IT Operations
"By leveraging Cognizant's expertise in the life sciences sector and innovative managed services frameworks, we will aim to accelerate our business outcomes and ultimately improve customer experiences," said Utilizing Cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance Alnylam's automation and reduce operational efforts
利用高知特頂級的託管服務框架和工具，合作伙伴旨在提高Alnylam的自動化水平並減少運營工作。
TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today a new agreement with Alnylam Pharmaceuticals, Inc., a leading biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics. Cognizant will serve as an integral IT Managed Services provider for Alnylam. This collaboration aims to scale Alnylam's IT operations and accelerate its capabilities in delivering transformative medicines.
新澤西州TEANECk，2024年10月29日 / PRNewswire/ - 納斯達克: CTSH的高知特（Cognizant）今天宣佈與領先的生物製藥公司Alnylam Pharmaceuticals，Inc.達成新協議，後者是RNA干擾（RNAi）治療領域的先驅。 高知特將作爲Alnylam的重要IT託管服務提供商。此次合作旨在擴大Alnylam的IT運營規模，並加快其在提供變革性藥物方面的能力。
Cognizant has been selected as the technology partner responsible for managing Alnylam's global infrastructure and operations, cloud, security, platforms, applications, and advanced data analytics. Leveraging Cognizant's managed services frameworks and tools, the collaboration aims to improve automation, reduce operational efforts, and ensure transparency in business decisions and unified performance accountability.
高知特被選定爲負責管理Alnylam全球基礎設施和運營、雲、安全、平台、應用和先進數據分析的技術合作夥伴。藉助高知特的託管服務框架和工具，此次合作旨在改善自動化水平，減少運營工作，並確保業務決策的透明度和統一績效責任。
"By leveraging Cognizant's expertise in the life sciences sector and innovative managed services frameworks, we will aim to accelerate our business outcomes and ultimately improve customer experiences," said Larry Egan, Vice President of Strategic Technologies at Alnylam.
Alnylam戰略技術副總裁Larry Egan表示：「通過利用高知特在生命科學領域和創新託管服務框架方面的專業知識，我們將努力加速業務成果，最終改善客戶體驗。」
Thirty of the top global pharmaceutical companies work with Cognizant to implement and manage advanced technology solutions, enabling them to bring their innovative drugs to market, run global supply chains and manufacturing systems, and comply with complex regulations.
全球30家頂尖製藥公司與高知特合作，實施和管理先進技術解決方案，使它們能夠將創新藥物推向市場，管理全球供應鏈和製造系統，以及遵守複雜的監管要求。
"We are thrilled to partner with Alnylam on its IT transformation journey," said Cognizant's Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences. "We will bring our extensive experience with large pharmaceutical companies, along with investments in AI, to accelerate Alnylam's business goals. As a strategic partner, we look forward to helping Alnylam grow its business and continue delivering transformative medicines to treat both rare and prevalent diseases."
高知特全球大型交易負責人兼生命科學事業部負責人Mohammad Haque表示：「我們很高興與Alnylam合作進行IT轉型之旅。我們將藉助我們在大型製藥公司的豐富經驗，以及對人工智能的投資，加速Alnylam達成業務目標。作爲戰略合作伙伴，我們期待幫助Alnylam擴大業務，並繼續提供治療罕見疾病和常見疾病的變革性藥物。」
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at or @cognizant.
關於高知特
高知特（納斯達克代碼：CTSH）致力於打造現代化的企業。我們幫助客戶現代化技術、重新構想流程和轉變經驗，以便他們在快速變化的世界中保持領先地位。我們共同改善日常生活。請在網站（http://www.cognizant.com/）或@Cognizant上了解更多信息。
Contact:
Natalie Steffen
[email protected]
聯繫方式：
Natalie Steffen
[email protected]
SOURCE Cognizant Technology Solutions
來源：高知特技術解決方案
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
